KR101972694B1 - Method for Preparing a Composition Comprising Allium ampeloprasum L. Extract and the Composition for Preventing or Improving Obesity Comprising the Same - Google Patents
Method for Preparing a Composition Comprising Allium ampeloprasum L. Extract and the Composition for Preventing or Improving Obesity Comprising the Same Download PDFInfo
- Publication number
- KR101972694B1 KR101972694B1 KR1020180001551A KR20180001551A KR101972694B1 KR 101972694 B1 KR101972694 B1 KR 101972694B1 KR 1020180001551 A KR1020180001551 A KR 1020180001551A KR 20180001551 A KR20180001551 A KR 20180001551A KR 101972694 B1 KR101972694 B1 KR 101972694B1
- Authority
- KR
- South Korea
- Prior art keywords
- garlic
- male
- extract
- composition
- present
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title claims abstract description 12
- 235000020824 obesity Nutrition 0.000 title claims abstract description 12
- 239000000284 extract Substances 0.000 title abstract description 17
- 239000000203 mixture Substances 0.000 title abstract description 15
- 240000006108 Allium ampeloprasum Species 0.000 title abstract description 9
- 235000005254 Allium ampeloprasum Nutrition 0.000 title abstract description 9
- 238000000034 method Methods 0.000 title abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 13
- 240000002234 Allium sativum Species 0.000 claims description 68
- 235000004611 garlic Nutrition 0.000 claims description 64
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical group CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 26
- 210000001789 adipocyte Anatomy 0.000 claims description 26
- 230000004069 differentiation Effects 0.000 claims description 22
- 235000020706 garlic extract Nutrition 0.000 claims description 13
- 239000006000 Garlic extract Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000006872 improvement Effects 0.000 claims description 2
- 230000005764 inhibitory process Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 18
- 230000014509 gene expression Effects 0.000 description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241000406668 Loxodonta cyclotis Species 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 230000003579 anti-obesity Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 241000383638 Allium nigrum Species 0.000 description 5
- 108010016731 PPAR gamma Proteins 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 102000012132 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 230000035508 accumulation Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 101000942967 Homo sapiens Leukemia inhibitory factor Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102100032352 Leukemia inhibitory factor Human genes 0.000 description 2
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- ZFAHNWWNDFHPOH-YFKPBYRVSA-N S-allylcysteine Chemical compound OC(=O)[C@@H](N)CSCC=C ZFAHNWWNDFHPOH-YFKPBYRVSA-N 0.000 description 2
- 241001504592 Trachurus trachurus Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 102000023732 binding proteins Human genes 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000006372 lipid accumulation Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 238000004260 weight control Methods 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000014777 Adipokines Human genes 0.000 description 1
- 108010078606 Adipokines Proteins 0.000 description 1
- 102000011690 Adiponectin Human genes 0.000 description 1
- 108010076365 Adiponectin Proteins 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 1
- 238000010806 PrimeScriptTM RT Reagent kit Methods 0.000 description 1
- ZFAHNWWNDFHPOH-UHFFFAOYSA-N S-Allyl-L-cystein Natural products OC(=O)C(N)CSCC=C ZFAHNWWNDFHPOH-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000011759 adipose tissue development Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001378 electrochemiluminescence detection Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N octadec-9-enoic acid Chemical compound CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 210000000229 preadipocyte Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000019565 spicy aroma Nutrition 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 108091008023 transcriptional regulators Proteins 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/212—Garlic
Abstract
Description
본 발명은 웅녀마늘 추출물의 제조방법 및 이를 포함하는 비만 예방 또는 개선용 조성물에 관한 것이다.The present invention relates to a method for producing Ungung garlic extract and a composition for preventing or improving obesity comprising the same.
우리나라 식생활에 있어 필수불가결한 식재료인 마늘은 전통적으로 향신료뿐만 아니라 항암, 항산화 및 향균 등 다양한 약리효능을 갖는 민간치료제로도 사용되어 왔다. 또한 마늘의 주요 유효성분인 allicin은 혈압강화, 혈중 지질 저하 및 혈당 감소효과 등 다양한 생리적 효능을 갖는다고 알려져 있다. 그러나, 생마늘의 경우 특유의 냄새와 향으로 인해 생리활성 효과를 나타내기 충분한 양을 지속적으로 섭취하기 어려울 뿐만 아니라 과량 섭취 시 위벽을 자극, 조직 손상을 야기할 수 있어 있다. 반면, 마늘을 가열 숙성한 흑마늘의 경우, 마늘 특유의 매운 맛과 향은 감소하고 단맛이 증가될 뿐만 아니라 제조과정 중 화학적 변환이 일어나면서 S-allylcysteine 와 같은 특정 생리활성 물질이 증가한다고 보고된 바 있다. 이러한 생리활성 물질들의 함량 차이로 인해 흑마늘은 일반마늘에 비해 항산화, 동맥경화 및 체내 지질 개선효과가 우수한 것으로 알려져 있다.Garlic, an indispensable ingredient in Korean diet, has traditionally been used as a folk remedy with various pharmacological effects such as anticancer, antioxidant and antibacterial as well as spices. In addition, allicin, the main active ingredient of garlic, is known to have various physiological effects such as blood pressure strengthening, blood lipid lowering and blood sugar reducing effect. However, in the case of raw garlic, it is difficult to continuously consume sufficient amount to exhibit a physiological activity effect due to its unique smell and aroma, and it may irritate the stomach wall and cause tissue damage when excessively ingested. On the other hand, black garlic heated by garlic has been reported not only to decrease the spicy taste and aroma of garlic, but also to increase the sweet taste, and to increase the specific bioactive substances such as S-allylcysteine due to chemical transformation during the manufacturing process. have. Due to the difference in the content of these bioactive substances, black garlic is known to have superior antioxidant, arteriosclerosis, and lipid enhancement effects than normal garlic.
코끼리마늘(Allium ampeloprasum L.)은 일반 마늘 (Allium sativum L.)에 비해 냄새가 적고 인편이 약 10배 가량 큰 부추속에 속하는 식물이다. 특히, 코끼리마늘은 일반마늘에 비해 조직감과 단맛이 뛰어나 보다 다양한 종류의 식품소재로 이용하기에 적합하다. Elephant garlic (Allium ampeloprasum L.) is a plant belonging to the allium with less smell and about 10 times larger scale than general garlic (Allium sativum L.). In particular, the garlic garlic has a superior texture and sweetness compared to general garlic, making it suitable for use as a variety of food materials.
종래 등록 특허 제10-1446528호에서 흑마늘을 이용한 식초 조성물 및 이의 제조 방법 등에 대해 개시하고 있으나,웅녀마늘을 이용한 조성물 등은 아직까지 연구되고 있지 않은 실정이다. 상기 등록 특허의 원재료는 마늘 (Allium sativum L.)이며, 본 발명에서 사용한 원재료는 코끼리마늘 (Allium ampeloprasum L.)로 원재료의 차이가 있다. 최근까지 국내 연구는 웅녀마늘의 생육에 관한 연구로 한정되어 있으며 이를 이용한 생리 활성효과에 대한 연구는 현저히 부족한 실정이다. 기존 등록 특허 등의 경우 마늘을 포함하는 경우만이 개시되어 있을 뿐, 웅녀마늘 (Allium ampeloprasum L.)을 이용한 연구는 전혀 개시되지 않았다. Conventional Patent No. 10-1446528 discloses a vinegar composition using black garlic and a method for preparing the same, but a composition using male garlic has not been studied until now. The raw material of the registered patent is garlic (Allium sativum L.), the raw material used in the present invention is the elephant garlic (Allium ampeloprasum L.), there is a difference in the raw material. Until recently, domestic research has been limited to the research on the growth of Ungung garlic, and the research on the biological activity effect using the same is not sufficient. In the case of the existing registered patents, only the case containing garlic is disclosed, and studies using allium garlic (Allium ampeloprasum L.) have not been disclosed at all.
이에 따라, 본 발명은 웅녀마늘을 이용한 우수한 효과를 지니는 비만예방 또는 개선용 조성물을 제공 하고자 한다. Accordingly, the present invention is to provide a composition for preventing or improving obesity having an excellent effect using the male garlic.
본 발명은 생으로 섭취하였을 때도 부작용이 적은 웅녀마늘을 이용하여, 냄새 발생이 적어 수시로 섭취 가능하며, 효과적인 비만 예방 또는 개선용 조성물을 제공하는 것에 목적이 있다. The present invention is to provide a composition for preventing or improving obesity, which can be ingested at any time due to the occurrence of odor less by using the male garlic with less side effects even when ingested raw.
본 발명은 웅녀마늘 추출물을 포함하는 비만 예방 또는 개선용 조성물을 제공한다.The present invention provides a composition for the prevention or improvement of obesity, including the male extract.
또한, 본 발명은 웅녀마늘을 균질화 시켜 균질화된 웅녀마늘을 수득하는 단계; 및 상기 균질화된 웅녀마늘을 용매와 혼합하여 용해시켜 웅녀마늘 추출물을 수득하는 단계를 포함하는 웅녀마늘 추출물 제조방법을 제공한다. In addition, the present invention comprises the steps of homogenizing the male garlic to obtain a homogenized male garlic; And it provides a method for producing Ungung garlic extract comprising the step of dissolving the homogenized Ungung garlic with a solvent to obtain a Ungung garlic extract.
본 발명은 웅녀마늘을 포함함으로써, 우수한 비만 예방 또는 치료 효과를 달성하는 것을 목적으로 한다.An object of the present invention is to achieve an excellent obesity prevention or treatment effect by including male garlic.
도 1은 생웅녀마늘 및 흑웅녀마늘이 3T3-L1지방전구세포 분화에 미치는 영향에 관한 도로, (A)는 3T3-L1지방 세포의 지질 축적에 URG 및 UBG(부탄올 가용성 분획)의 효과에 관한 것으로, 지질 방울을 Oil Red O 용액으로 염색하고 100배 배율로 촬영한 도 이다(오른쪽 아래 그림은 400x 배율의 현미경으로 촬영한 그림으로, 전지방세포(preadipocytes)를 음성대조군(NC)으로 하고, 완전 분화 지방세포를 양성 대조군으로 하였고, (B)는 495nm에서 측정된 염색 세포의 흡광도와 관련된 도이며, (C)는 3T3-L1지방전구세포의 지질 축적에 대한 REG 또는 SEG(에탄올 가용성 분획)의 효과에 관한 도이다.
도 2는 REG 또는 SEG가 지방생성과정에 관여하는 유전자의 mRNA 발현에 미치는 영향에 관한 도로서, (A)는 3T3-L1지방전구세포를 분화기간 동안 SEG 또는 REG로 처리하여, 분화 8일후, 총 RNA 를 분리하고 RT-PCR에 의해 지방형성 관련 유전자의 발현에 관한 도이며, (B)는 정량프로그램 (image J)를 이용한 유전자 발현의 정량화에 관한 도이다.
도 3은 REG 또는 SEG가 지방생성과정에 관여하는 단백질 발현에 미치는 영향에 관한 도로서, (A)는 분화기간동안 SEG 또는 REG로 처리된 세포를 용해시키고 총 단백질을 추출하여, PPARγ와 C / EBPα의 단백질 발현을 웨스턴 블롯으로 분석한 도로, β- 액틴을 사용한 동등한 양의 로딩을 확인 하였다. (B)정량화된 단백질 발현에 관한 도이다. 1 is a road related to the effect of lively and black female garlic on the differentiation of 3T3-L1 adipocytes, (A) the effect of URG and UBG (butanol soluble fraction) on the lipid accumulation of 3T3-L1 adipocytes Lipid droplets were stained with Oil Red O solution and photographed at 100-fold magnification (lower right picture, taken with a microscope at 400x magnification, with preadipocytes as negative control, Fully differentiated adipocytes were positive controls, (B) is a diagram related to the absorbance of stained cells measured at 495 nm, and (C) is REG or SEG (ethanol soluble fraction) for lipid accumulation of 3T3-L1 adipocytes It is a diagram regarding the effect of.
Figure 2 is a diagram showing the effect of REG or SEG on the mRNA expression of genes involved in the adiogenesis process, (A) is treated with SEG or REG during the differentiation period, 8 days after differentiation, Total RNA is isolated and the expression of fat-associated genes by RT-PCR, (B) is a diagram for the quantification of gene expression using a quantitation program (image J).
3 is a diagram showing the effect of REG or SEG on the protein expression involved in adiogenesis process, (A) lysing the cells treated with SEG or REG during the differentiation period and extract the total protein, PPARγ and C / Road analysis of protein expression of EBPα was confirmed by Western blot, confirming the equivalent amount loading with β-actin. (B) is a diagram of quantified protein expression.
본 발명은 웅녀마늘 추출물을 포함하는 비만예방 또는 개선용 조성물을 제공한다.The present invention provides a composition for preventing or improving obesity, including a male extract garlic.
본 명세서에서 웅녀 마늘이라 함은, 백합목 백합과에 속하는 커다란 구근 식물로, 코끼리 마늘(Elephant garlic)이라고 명명되기도 하며, 학명은 Allium ampeloprasum인 식물을 의미한다. In the present specification, the male garlic is a large bulbous plant belonging to the genus Liliaceae, and may also be called elephant garlic, and the scientific name refers to a plant of Allium ampeloprasum .
본 발명에 있어서, 상기 추출물은 부탄올, 헥산 및 에틸알코올으로 이루어진 군으로부터 선택되는 1종 이상의 용매를 포함하는 것일 수 있으며, 부탄올을 용매로 포함할 경우 지방세포 분화억제효과가 우수할 수 있다는 점에서 보다 바람직 할 수 있다. In the present invention, the extract may include one or more solvents selected from the group consisting of butanol, hexane and ethyl alcohol, in that the butanol as a solvent may be excellent in inhibiting the adipocyte differentiation effect It may be more desirable.
본 발명에 있어서, 상기 웅녀마늘 추출물은 생웅녀마늘, 흑웅녀마늘 및 흑웅녀마늘 열수추출물로 이루어진 군으로부터 선택되는 1종 이상을 포함할 수 있으며, 흑웅녀마늘을 포함할 경우 독성없이 지방세포분화를 억제함으로써 항비만 효과를 나타낼 수 있다는 점에서 보다 우수할 수 있다는 점에서 보다 바람직 할 수 있다. In the present invention, the male and female garlic extract may include one or more selected from the group consisting of raw male garlic, black female garlic and black female garlic hot water extract, and fat cell differentiation without toxicity when the male black garlic is included. It may be more preferable in that it can be better in that it can exhibit an anti-obesity effect by suppressing.
본 발명은 웅녀마늘을 균질화 시켜 균질화된 웅녀마늘을 수득하는 단계; 및 The present invention comprises the steps of homogenizing the male garlic to obtain a homogenized male garlic; And
상기 균질화된 웅녀마늘을 용매와 혼합하여 용해시켜 웅녀마늘 추출물을 수득하는 단계를 포함하는 웅녀마늘 추출물 제조방법을 제공한다. It provides a method for producing Ungung garlic extract comprising the step of dissolving the homogenized Ungung garlic with a solvent to obtain a Ungung garlic extract.
본 발명에 있어서, 상기 용매는 부탄올, 헥산 및 에틸알코올으로 이루어진 군으로부터 선택되는 1종 이상의 용매일 수 있으며, 부탄올이 보다 바람직 할 수 있다. In the present invention, the solvent may be at least one solvent selected from the group consisting of butanol, hexane and ethyl alcohol, butanol may be more preferred.
본 발명에 있어서, 상기 웅녀마늘은 생웅녀마늘, 흑웅녀마늘 및 흑웅녀마늘 열수추출물로 이루어진 군으로부터 선택되는 1종 이상일 수 있다. In the present invention, the male and female garlic may be one or more selected from the group consisting of raw male garlic, black female garlic and black female garlic hot water extract.
본 발명에 있어서, 상술한 조성물은 웅녀마늘 추출물에 대하여 중량부 기준으로, 용매를 1:1 내지 1:100 혼합할 수 있다. In the present invention, the composition described above may be mixed 1: 1 to 1: 100 of the solvent, based on the weight part with respect to the male garlic extract.
본 발명에 있어서, 상기 흑웅녀마늘은 찜기를 이용하여 80 내지 90℃에서 12 시간 내지 56시간 가열 이후 80 내지 90℃에서 6시간 내지 72시간 숙성하는 단계를 포함할 수 있으며, 상기 과정을 통해 제조한 흑 웅녀마늘의 경우 세포독성 없이 항비만 효과를 가진다는 점에서 바람직하다. 본 발명의, 흑웅녀마늘은 찜기(제조사:홍삼본가, 모델명:HK-9600)를 이용하여 86 ℃ 에서 24시간 가열 후, 증기를 이용하여 86℃ 에서 12시간 동안 숙성하였다.In the present invention, the black female garlic may include a step of aging 6 hours to 72 hours at 80 to 90 ℃ after heating for 12 hours to 56 hours at 80 to 90 ℃ using a steamer, prepared through the process One black male garlic is preferable in that it has anti-obesity effect without cytotoxicity. Black horseradish garlic of the present invention was heated at 86 ° C. for 24 hours using a steamer (manufacturer: red ginseng book family, model name: HK-9600), and aged at 86 ° C. for 12 hours using steam.
본 발명의 웅녀마늘 추출물을 포함하는 조성물은, 비만예방 또는 개선용 조성물로서, 식품 조성물 또는 기능성 식품 조성물일 수 있다. The composition comprising the male extract of the present invention may be a food composition or a functional food composition as a composition for preventing or improving obesity.
이하, 본 명세서를 구체적으로 설명하기 위해 실시예를 들어 상세히 설명한다. 그러나, 본 명세서에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 명세서의 범위가 아래에서 상술하는 실시예들에 한정되는 것으로 해석되지는 않는다. 본 명세서의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 명세서를 보다 완전하게 설명하기 위해 제공되는 것이다. 또한, 이하에서 함유량을 나타내는 “%” 및 “부”는 특별히 언급하지 않는 한 중량 기준이다.Hereinafter, the present invention will be described in detail with reference to Examples. However, the embodiments according to the present disclosure may be modified in various other forms, and the scope of the present specification is not to be interpreted as being limited to the embodiments described below. The embodiments of the present specification are provided to more fully describe the present specification to those skilled in the art. In addition, "%" and "part" which show content below are a basis of weight unless there is particular notice.
이하 본 발명의 구성을 바람직한 예로 적시된 아래의 실시예를 통해 보다 구체적으로 설명한다. 웅녀마늘(코끼리마늘)은 일반 마늘에 비해 발효된 웅녀 흑마늘에서 총 피루브산의 함량이 큰 폭으로 증가함을 보인 바 있으며, 웅녀마늘은 항비만 활성이 있는 scopoletin을 포함하고 있다고 알려진 바 있다.Hereinafter, the configuration of the present invention will be described in more detail with reference to the following examples indicated as preferred examples. The male garlic (Elephant garlic) has shown a significant increase in the total pyruvic acid content in fermented male black garlic compared to normal garlic, and male female garlic has been known to contain scopoletin, which has anti-obesity activity.
제조예Production Example 1. 용매별 시료의 제조 1. Preparation of solvent-specific samples
본 연구에서는 경상북도 군위군에서 재배 및 수확된 웅녀마늘을 군위기술센터로부터 지원받아 생웅녀마늘(Raw Elephant Rarlic, REG), 흑웅녀마늘(Steam Elephant Garlic, SEG) 및 흑웅녀마늘 열수추출물(Steam Elephant Garlic Extract, SEGE)과 같은 세가지 종류의 코끼리마늘 추출물을 제조하였다. 생웅녀마늘(REG)의 경우 껍질을 제거하고 세척, 건조 및 갈아 균질화하였다. 흑웅녀마늘(SEG) 및 흑웅녀마늘 열수추출물(SEGE)의 경우 찜기를 이용하여 2L의 증류수와 함께 가열 후 12시간 숙성하였다. 숙성된 흑웅녀마을은 증류수 없이 혹은 증류수와 함께 1:1 비율로 갈아 균질화 하였으며 본 연구에서는 이를 각각 흑웅녀마늘, 흑웅녀마늘 열수추출물이라고 명명하였다. 균질화 된 각 웅녀마늘은 70% hexane, 70% ethyl alchol, 및 butanol에 1:1 비율 (중량기준) 로 혼합 후 진탕배양기를 이용하여 30시간 동안 200rpm에서 용해하였다. 용해된 추출물은 회전식진공농축기를 이용하여 완전 건고 후 DMSO를 이용하여 일정한 농도로 희석, membrane filter (0.22-um pore size)로 제균 후 항암 및 항비만 효과 분석을 위한 실험 시료로 사용하였다In this study, the cultivated and harvested Ungyeom garlic in Gyeongsangbuk-do, Uigun-gun was supported by the Army Technical Technology Center. Three kinds of elephant garlic extracts were prepared. In the case of raw female garlic (REG), the skin was removed, washed, dried and ground homogenized. Black female garlic (SEG) and black female garlic hot water extract (SEGE) were aged for 12 hours after heating with 2 L of distilled water using a steamer. The aged black horse villages were homogenized by distilled water with or without distilled water in a 1: 1 ratio. In this study, they were named as black horse mackerel garlic and black horse mackerel garlic hot water extract. Each homogenized garlic was mixed in 70% hexane, 70% ethyl alchol, and butanol in a 1: 1 ratio (by weight) and then dissolved at 200 rpm for 30 hours using a shaker incubator. The dissolved extract was completely dried using a rotary vacuum concentrator, diluted to a constant concentration using DMSO, and used as a test sample for analysis of anticancer and anti-obesity effects after sterilization with a membrane filter (0.22-um pore size).
실험예Experimental Example 1. 세포배양 1. Cell Culture
3T3-L1 지방전구세포는 한국세포주은행(KCLB) 으로부터 분양 받은 후, 10% Newborn Calf Serum, 1% antibiotics를 포함하는 DMEM 배지에 5% CO2가 공급되는 37℃ incubator에서 배양하였다. After 3T3-L1 adipocytes were distributed from Korea Cell Line Bank (KCLB), they were cultured in a 37 ° C. incubator supplied with 5% CO 2 in DMEM medium containing 10% Newborn Calf Serum and 1% antibiotics.
실험예Experimental Example 2. 지방세포 분화 유도 2. Induction of adipocyte differentiation
3T3-L1 지방전구세포(preadipoycytes)를 성숙한 지방세포(mature adipocytes)로 분화 유도하기 위해서, 6well-plate에 분주 뒤, 세포가 100% confluent가 되었을 때 MDI solution (0.5 mM IBMX, 0.25 μM DEX, 167 nM insulin, and 100 μM indomethacin)이 포함된 10% FBS를 포함하는 DMEM 배지로 교체 해주었다. 분화유도 2틀 뒤, 167 nM insulin의 insulin이 포함된 배지로 교체해 주었다. 배양 중인 세포의 배지는 2일 간격으로 새로운 insulin이 포함된 배지로 교체해주었다. 웅녀마늘의 지방세포 분화억제 효과를 관찰하기 위하여, 분화기간 동안 (총 8일) REG, SEG 또는 SEGE를 2, 4mg/ml 의 농도로 처리하였다. In order to induce differentiation of 3T3-L1 preadipoycytes into mature adipocytes, after dispensing on a 6-well plate, when the cells became 100% confluent, MDI solution (0.5 mM IBMX, 0.25 μM DEX, 167 nM insulin, and 100 μM indomethacin) were replaced with DMEM medium containing 10% FBS. Two days after the induction of differentiation, the medium was replaced with a medium containing insulin of 167 nM insulin. The medium of the cells in culture was replaced with a medium containing fresh insulin every two days. In order to observe the inhibitory effect of adipocyte differentiation of male garlic, REG, SEG or SEGE was treated at a concentration of 2, 4 mg / ml during the differentiation period (total 8 days).
실험예Experimental Example 3. 세포 내 지질 염색 (Oil Red O staining, 3. Intracellular Lipid Staining (Oil Red O staining, OROORO ))
분화가 완료된 성숙한 3T3-L1 지방세포의 세포 내 lipid droplet을 확인하기 위해, ORO 염색을 수행하였다. 분화가 완료된 3T3-L1 세포를 0.6% Glutaraldehyde로 상온에서 1시간 동안 고정, 60% isopropyl alcohol로 세척 한 후 0.4% ORO soultion으로 상온에서 20분간 염색하였다. 염색된 세포를 촬영하고 100% isopropyl alcohol로 ORO solution을 용해하여 570nm에서 흡광도를 측정하여 정량화 하였다. To identify lipid droplets in the cells of mature 3T3-L1 adipocytes that were differentiated, ORO staining was performed. Differentiated 3T3-L1 cells were fixed with 0.6% Glutaraldehyde at room temperature for 1 hour, washed with 60% isopropyl alcohol and stained with 0.4% ORO soultion for 20 minutes at room temperature. Stained cells were photographed and quantified by measuring the absorbance at 570 nm by dissolving ORO solution with 100% isopropyl alcohol.
실험예Experimental Example 4. 세포 내 4. Intracellular mRNAmRNA 발현 수준 측정 Expression level measurement
세포 내 total RNA를 RNAiso Plus reagent (TaKaRa Bio, Japan)를 이용하여 분리한 이후, complimentary DNA (cDNA) 합성은 Prime-Script RT reagent Kit (TaKaRa Bio, Japan)를 이용하여 제조사의 메뉴얼에 따라 수행하였다. PCR조건은 94℃에서 30초(denaturation), 60℃에서 30초(annealing), 72℃ 에서 45초(extension)로 30-35번 반복 설정하였고 생성된 산물은 1.2% agarose gel에서 전기영동 하여 분리하고 ethidium bromide로 염색하여 시각화하였다. After intracellular total RNA was isolated using RNAiso Plus reagent (TaKaRa Bio, Japan), complimentary DNA (cDNA) synthesis was performed according to the manufacturer's manual using Prime-Script RT reagent Kit (TaKaRa Bio, Japan). . PCR conditions were repeated 30-35 times with 30 seconds (denaturation) at 94 ℃, 30 seconds (annealing) at 60 ℃, 45 seconds (extension) at 72 ℃ and the resulting product was separated by electrophoresis on 1.2% agarose gel And stained with ethidium bromide and visualized.
실험예Experimental Example 5. 세포 내 단백질 발현 수준 측정 5. Measurement of Protein Expression Level in Cells
세포를 lysis buffer((Biosesang, Seongnam, Korea)에 용해한 뒤 4°C에서 30분간 방치한 후 세포 용액을 12,000 rpm에서 15분간 원심 분리하였다. 동량의 단백질 (30μg) 을 10% SDS polyacrylamide gel에 의해 분리시켰다. gel내의 단백질을 Nitrocellulose Membrane(Amersham Protran Premium 0.2μm NC, GE Healthcare Life Sciences, Germany) 에 전달 시킨 뒤 5% skim milk로 1시간 동안 blocking하였다. 그 후, 1차 항체를 4℃ 에서 overnight 처리하였고 2차 항체는 상온에서 1시간 반응시켰다. 반응 후, enhanced chemiluminescence reagent (GEHealthcare, Buckinghamshire, UK) 를 membrane에 도포하고 FUSION Solo apparatus (Vilber Lourmat) 를 이용하여 검출하였다.The cells were dissolved in lysis buffer ((Biosesang, Seongnam, Korea) and left for 30 minutes at 4 ° C, and then the cell solution was centrifuged at 12,000 rpm for 15 minutes.The same amount of protein (30μg) was purified by 10% SDS polyacrylamide gel. The protein in the gel was transferred to Nitrocellulose Membrane (Amersham Protran Premium 0.2 μm NC, GE Healthcare Life Sciences, Germany) and blocked with 5% skim milk for 1 hour, after which the primary antibody was kept at 4 ° C. overnight. After the reaction, the secondary antibody was reacted for 1 hour at room temperature After the reaction, an enhanced chemiluminescence reagent (GEHealthcare, Buckinghamshire, UK) was applied to the membrane and detected using a FUSION Solo apparatus (Vilber Lourmat).
실험예Experimental Example 6. 통계처리 6. Statistical Processing
3회 반복한 실험결과는 평균 및 표준편차를 표시하였으며, 각 군 간의 통계적 유의성에 대한 검증은 SPSS 통계프로그램 (SPSS Inc.) 을 이용하여 일원배치 분산분석을 실시, 유의성 여부를 판정하였다 (*P<0.05, **P<0.01).The results of the experiments repeated three times indicated the mean and standard deviation, and the statistical significance between groups was analyzed by one-way batch analysis using SPSS Inc. (SPSS Inc.) to determine the significance (* P <0.05, ** P <0.01).
실험예Experimental Example 7. 7. REGREG , , SEGSEG 및 And SEGE가SEGE 3T3- 3T3- L1지방전구세포L1 fat precursor cells 분화에 미치는 영향 Impact on Differentiation
지방방울 (Lipid droplet)은 지방전구세포가 성숙한 지방세포로 분화하는 분화과정 (Adipogenesis)의 가장 큰 특징 중 하나이며 지방방울은 주로 중성지방인 triglyceride (TG)로 구성되어 있다. TG는 포도당과 같은 중요한 에너지원이지만 과다섭취 할 경우 지방세포에 흡수되어 저장되고 이는 비만의 원인으로 작용한다. 따라서, 본 연구에서는 REG, SEG 및 SEGE가 3T3-L1 지방전구세포가 분화하는 동안 세포 내 축적되는 지방방울의 축적에 영향을 미치는지 조사하였다. Lipid droplet is one of the most characteristic features of Adipogenesis in which the progenitor cells differentiate into mature adipocytes. Lipid droplets are mainly composed of triglyceride (TG), a triglyceride. TG is an important energy source such as glucose, but when excessively ingested, it is absorbed and stored in fat cells, which causes obesity. In this study, we investigated whether REG, SEG and SEGE affect the accumulation of fat droplets accumulated in cells during differentiation of 3T3-L1 adipocytes.
처음으로, 코끼리마늘을 세 가지 다양한 용매 (hexane, 70% ethyl alchol, 및 butanol)에서 추출한 각 코끼리마늘 추출물들을 모두 동일한 농도로 3T3-L1세포에 처리하였다. 그 결과, 세 가지 추출물에서 전반적으로 Butanol 분획층 에서 가장 우수한 지방세포분화 억제효과를 보였다 (data not shown). 이에 따라, 하위 연구에서는 Butanol 분획층을 단독으로 사용하였다. For the first time, elephant garlic extracts extracted from three different solvents (hexane, 70% ethyl alchol, and butanol) were treated with 3T3-L1 cells at the same concentration. As a result, the three extracts showed the best inhibitory effect of adipocyte differentiation in Butanol fractionation layer (data not shown). Therefore, Butanol fractionation layer was used alone in the lower study.
다음으로, Butanol층에서 추출한 REG, SEG를 세포가 분화하는 기간 내내 2, 4mg/ml로 처리하고 ORO 염색을 수행하였다. 실험 결과, REG와 SEG 모두 지방세포의 지방방울 축적을 농도의존적으로 억제하는 것을 확인하였다 (도 1A 및 B참조). 세포 내 ORO가 염색된 지방구를 정량분석 한 결과, 대조군 (PC)과 비교하여 4mg/ml 농도의 REG 및 SEG 처리는 각각 57.3%, 64.8% 지방세포 분화를 억제하였다 (도. 1B 참조).Next, REG and SEG extracted from the Butanol layer were treated with 2, 4 mg / ml throughout the period of differentiation of cells and ORO staining was performed. As a result of the experiment, it was confirmed that both REG and SEG suppressed fat accumulation of adipocytes in a concentration-dependent manner (see FIGS. 1A and B). As a result of quantitative analysis of intracellular ORO stained adipose cells, REG and SEG treatment at 4 mg / ml concentration inhibited 57.3% and 64.8% adipocyte differentiation, respectively, compared to the control (PC) (see FIG. 1B).
그러나, ORO가 염색되지 않은 미분화 세포의 모양을 확인했을 때 REG를 처리한 세포의 경우 세포모양이 변형되면서 세포손상이 야기된 것을 확인할 수 있었다. 그러므로, REG의 지방방울 축적억제효과는 지방분화과정의 억제를 통해서가 아닌 외부자극에 의한 세포사멸를 유도함으로써 발생된 현상이라고 추측된다. 추가적으로, 에탄올에서 추출한 SEG, SEGE 는 상기결과에서 보이는 부탄올에서 추출된 각 추출물보다 지방세포 분화억제능이 낮았으며 SEGE는 SEG보다 분화억제능이 낮음을 확인하였다 (도 1C참조). However, when confirming the appearance of undifferentiated cells that are not stained ORO, the cells treated with REG were found to cause cell damage as the cell shape was modified. Therefore, the effect of REG on the accumulation of fat droplets is presumed to be caused by induction of cell death by external stimulation and not by inhibition of fat differentiation process. In addition, SEG and SEGE extracted from ethanol were lower in adipocyte differentiation inhibitory activity than each extract extracted from butanol shown in the above results, and SEGE was found to be lower in differentiation inhibitory activity than SEG (see FIG. 1C).
상기의 결과를 바탕으로 우리는 다양한 방식으로 조리 및 다양한 용매에서 추출한 코끼리마늘 추출물 중 부탄올 분획층의 SEG가 가장 우수한 지방세포 분화억제능을 갖는다는 것을 확인하였다. Based on the above results, we confirmed that the SEG of butanol fractionation layer has the best adipocyte differentiation inhibitory ability among elephant garlic extracts cooked in various ways and extracted from various solvents.
실험예Experimental Example 8. 8. SEG가SEG 지방생성과정에 관여하는 유전자의 Of genes involved in fat production mRNAmRNA 및 단백질 발현에 미치는 영향 And influence on protein expression
지방세포 분화과정에서 REG 및 SEG 가 3T3-L1 지방세포 분화 관련인자들의 발현에 미치는 영향을 알아보기 위해 지방형성과정에 관여하는 주요전사조절인자인 peroxisome proliferator-activated receptor gamma (PPARgamma), CCAAT/enhancer-binding protein alpha (C/EBPalpha) 와 아디포카인 (adipocytokine)인 adiponectin 및 분화마커인 ap2 (fatty acid-bindingproteins), 저밀도지단백-콜레스테롤(low density lipoprotein, LDL)의 mRNA 발현 수준을 비교 분석하였다. 대조군과 비교하여 SEG의 처리는 PPARgamma, C/EBPalpha, ap2 및 LPL의 발현을 억제하였다 (도 2A 및 B 참조). 반면, REG는 다양한 지방세포 분화관련인자의 발현 억제율이 SEG보다 낮거나 억제시키지 못했다. SEG 및 REG에 의한 PPARgamma와 C/EBPalpha의 mRNA 발현량 감소는 단백질 수준에서도 동일한 결과를 보였다 (도 3A 및 B참조).Peroxisome proliferator-activated receptor gamma (PPARgamma), CCAAT / enhancer, major transcriptional regulators involved in adipose formation, to investigate the effects of REG and SEG on the expression of 3T3-L1 adipocyte differentiation factors in adipocyte differentiation. mRNA expression levels of -binding protein alpha (C / EBPalpha), adiponectin (adipocytokine), atypic acid-binding proteins (p2), and low density lipoprotein (LDL), differentiation markers, were compared. Treatment of SEG compared to the control inhibited the expression of PPARgamma, C / EBPalpha, ap2 and LPL (see FIGS. 2A and B). On the other hand, REG did not inhibit or suppress the expression of various adipocyte differentiation-related factors below SEG. Reduction of mRNA expression levels of PPARgamma and C / EBPalpha by SEG and REG showed the same results at the protein level (see FIGS. 3A and B).
즉, 생 웅녀마늘, 흑웅녀마늘 및 흑웅녀마늘 열수 추출물 등은, 항비만 효과를 가지며, 특히 흑웅녀마늘이 3T3-L1 지방세포의 분화를 효과적으로 억제함으로써 생체 외 항비만효과를 가질 수 있음을 확인 하였다. 따라서, 본 발명이 제공하는 웅녀마늘 추출물을 포함할 경우, 체중조절기능을 갖는 건강기능식품 및 의약품등으로 활용 가능한 것이다. That is, raw male garlic, black female garlic, and black female garlic hot water extract have anti-obesity effects, and in particular, black female garlic can have an in vitro anti-obesity effect by effectively inhibiting the differentiation of 3T3-L1 adipocytes. Confirmed. Therefore, when the ungna garlic extract provided by the present invention, it can be utilized as health functional foods and medicines having a weight control function.
다만, 흑웅녀마늘과 동일하게 생웅녀마늘은 지방세포 분화 억제효과를 가졌지만 이는 세포독성효과에 기인할 수 있으므로, 이러한 독성효과는 체중조절목적으로 생웅녀마늘을 섭취했을 때, 생체 내 조직손상 및 정상세포파괴 등을 부작용을 동반할 수 있으나, 비만의 예방용 개선용 효과가 우수함을 확인하였다. However, as in black female garlic, live female garlic had a fat cell differentiation inhibitory effect, but this may be due to cytotoxic effect. Thus, this toxic effect is caused by tissue damage in vivo when ingested raw female garlic for weight control purposes. And normal cell destruction may be accompanied by side effects, but it was confirmed that the effect of improving the prevention of obesity is excellent.
이상의 설명은 본 발명을 예시적으로 설명한 것에 불과한 것으로, 본 발명이 속하는 기술분야에서 통상의 지식을 가지는 자라면 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 다양한 변형이 가능할 것이다. 따라서, 본 명세서에 개시된 실시예들은 본 발명을 한정하기 위한 것이 아니라 설명하기 위한 것이고, 이러한 실시예에 의하여 본 발명의 사상과 범위가 한정되는 것은 아니다. 본 발명의 보호범위는 청구범위에 의하여 해석되어야 하며, 그와 동등한 범위 내에 있는 모든 기술은 본 발명의 권리범위에 포함하는 것으로 해석되어야 할 것이다.The above description is merely illustrative of the present invention, and those skilled in the art to which the present invention pertains may various modifications without departing from the essential characteristics of the present invention. Accordingly, the embodiments disclosed herein are not intended to limit the present invention but to describe the present invention, and the spirit and scope of the present invention are not limited by these embodiments. The scope of protection of the present invention should be construed by the claims, and all descriptions within the equivalent scope should be construed as being included in the scope of the present invention.
Claims (10)
상기 균질화된 웅녀마늘을 용매와 1:1 중량비로 혼합하여 용해시켜 웅녀마늘 추출물을 수득하는 단계를 포함하며,
상기 웅녀마늘은 흑웅녀마늘이고, 상기 용매는 부탄올이고,
상기 균질화된 웅녀마늘을 수득하는 단계는,
웅녀마늘을 80 내지 90℃ 에서 12 시간 내지 56시간 동안 가열한 후, 80 내지 90℃ 에서 6시간 내지 72시간 동안 숙성하는 단계; 및
상기 숙성된 웅녀마늘을 균질화시키는 단계;를 포함하여,
지방세포 분화를 64.8% 억제하는, 비만예방 또는 개선용 웅녀마늘 추출물 제조방법. Homogenizing the male garlic to obtain a homogenized male garlic; And
Comprising the homogenized Ungung garlic with a solvent in a 1: 1 weight ratio to dissolve to obtain a Ungung garlic extract,
The male garlic is black female garlic, the solvent is butanol,
Obtaining the homogenized male garlic,
Heating the male garlic for 12 to 56 hours at 80 to 90 ° C., and then for 6 to 72 hours at 80 to 90 ° C .; And
Homogenizing the aged male garlic; including,
64.8% inhibition of adipocyte differentiation, obesity prevention or improvement for manung garlic extract manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180001551A KR101972694B1 (en) | 2018-01-05 | 2018-01-05 | Method for Preparing a Composition Comprising Allium ampeloprasum L. Extract and the Composition for Preventing or Improving Obesity Comprising the Same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180001551A KR101972694B1 (en) | 2018-01-05 | 2018-01-05 | Method for Preparing a Composition Comprising Allium ampeloprasum L. Extract and the Composition for Preventing or Improving Obesity Comprising the Same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101972694B1 true KR101972694B1 (en) | 2019-08-16 |
Family
ID=67806771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180001551A KR101972694B1 (en) | 2018-01-05 | 2018-01-05 | Method for Preparing a Composition Comprising Allium ampeloprasum L. Extract and the Composition for Preventing or Improving Obesity Comprising the Same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101972694B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100959513B1 (en) * | 2009-12-01 | 2010-05-27 | 새남해농업협동조합 | The method of aging black garlic |
KR101446528B1 (en) | 2012-01-20 | 2014-11-04 | 의성농산영농조합법인 | Vinegar Composition Fermented with Black Garlic and Preparation Method Thereof |
KR20150085543A (en) * | 2014-01-15 | 2015-07-24 | 한국식품연구원 | Composition for Improving, Preventing or Treating Obesity Comprising Allium sativum L. Extracts and Momordica charanti Extract |
-
2018
- 2018-01-05 KR KR1020180001551A patent/KR101972694B1/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100959513B1 (en) * | 2009-12-01 | 2010-05-27 | 새남해농업협동조합 | The method of aging black garlic |
KR101446528B1 (en) | 2012-01-20 | 2014-11-04 | 의성농산영농조합법인 | Vinegar Composition Fermented with Black Garlic and Preparation Method Thereof |
KR20150085543A (en) * | 2014-01-15 | 2015-07-24 | 한국식품연구원 | Composition for Improving, Preventing or Treating Obesity Comprising Allium sativum L. Extracts and Momordica charanti Extract |
Non-Patent Citations (1)
Title |
---|
웅녀마늘 연구용역 최종보고회, 경북매일 (게재일:2016.11.14.) * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105796546B (en) | SIRT1 activator containing syringaresinol | |
KR101930483B1 (en) | Smilax china leaf fermented with Aspergillus species and Extract of the same | |
Bunkrongcheap et al. | Ivy gourd (Coccinia grandis L. Voigt) root suppresses adipocyte differentiation in 3T3-L1 cells | |
JP2012149004A (en) | Activator of nuclear receptor | |
JP5171097B2 (en) | Heparin-binding epidermal growth factor-like growth factor gene expression promoter containing plant extract | |
KR101972694B1 (en) | Method for Preparing a Composition Comprising Allium ampeloprasum L. Extract and the Composition for Preventing or Improving Obesity Comprising the Same | |
KR20150053321A (en) | Anti obesity Composition comprising anthocyanin originated from black bean peels as an active ingredient | |
KR102120220B1 (en) | Cosmetic or food composition comprising natural plants fermented extracts for reducing abdominal obesity | |
KR102438938B1 (en) | Vitalmelon (KCTC14699BP) and anti-obesity composition comprising vitalmelon extract | |
US10183048B2 (en) | Composition for promoting the activity of peroxisome proliferator-activated receptor-delta | |
KR20150085991A (en) | Skin whitening compositions containing oriental medicine natural herb | |
JP2019052109A (en) | Muscle formation promoting composition | |
KR101754149B1 (en) | Anti-Obesity Food Composition Containing Solidago Virgaurea Extract and Method for Preparing the Same | |
KR101629318B1 (en) | Method for producing curry sauce containing barley sprout with increased anti-obesity | |
KR20070068837A (en) | Extracts from the seed of rosa multiflora for inhibiting the differentiation of adipocytic cells | |
JP2009249331A (en) | Plant-originated agent for preventing or ameliorating hyperlipemia | |
KR101901491B1 (en) | Anti-obesity composition containing absolute or cinnamyl alcohol extracted from castanea crenata var. dulcis flower | |
KR20190011919A (en) | Nrf2 activating composition containing radish extract as an active ingredient and a method for producing the radish extract | |
KR101699152B1 (en) | A composition comprising the complex extract of Trigonella foenum-graecum L. and Black Ginseng for preventing or treating Andropause Symptoms | |
JP6050596B2 (en) | Nuclear receptor activity promoter and method for promoting nuclear receptor activity | |
US10905703B2 (en) | Preparation of a composition containing stilbene glycoside | |
KR20160094161A (en) | Anti-dark circle composition comprising Scutellaria baicalensis extract | |
KR20230143490A (en) | Colored wheat extract exhibiting anti-obesity function and food composition containing the extract | |
KR20170054025A (en) | Method of Manufacturing Black Adzuki Bean Roasted Tea for Preventing Obesity and Controlling Blood Sugar And Black Adzuki Bean Roasted Tea By Using The Same | |
KR20170105928A (en) | Orally administered composition for preventing or improving mental disorder comprising hydroponic-cultured panas ginseng extract and rhynchosia nulubilis extract |